By Jefferey Jaxen

In what is becoming a common occurrence, the U.S. Food and Drug Administration (FDA) has omitted convening their Vaccines and Related Biological Products Advisory Committee (VRBPAC) to weight the data and vote on its recent approval of a Pfizer booster for children 12-15 years old.

The move was not lost on members of the scientific community. Surgical oncologist and chief of the Johns Hopkins Islet Transplant Center Marty Makary, MD, MPH wrote on Twitter:

Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research was quoted in the FDA’s recent press releases stating:

“Based on the FDA’s assessment of currently available data, a booster dose of the currently authorized vaccines may help provide better protection against both the delta and omicron variants. In particular, the omicron variant appears to be slightly more resistant to the antibody levels produced in response to the primary series doses from the current vaccines,”

However, on August 18, 2020 in an article written by Marks in HealthAffairs.org he, along with then acting FDA commissioner Stephan Hahn, claimed “[the] FDA has committed to use an advisory committee composed of independent experts to ensure deliberations about authorization or licensure are transparent for the public.

They also wrote, “By convening VRBPAC, FDA will ensure public transparency around discussions of vaccine safety and effectiveness to provide a window into its decision-making process and help address potential concerns from vaccine-hesitant populations.

In addition to not convening their VRBPAC committee, the FDA’s recent ‘science by press release’ statement made no mention of new trials. In fact, they appear to be basing their EUA extension in children based on “real-world data from Israel”.

Senator Rand Paul wrote:

Meanwhile, overall data analysis continues to show that the danger to children of SARS-COV-2 and its recent omicron variant, is low compared to older populations and especially those with comorbidities.

Even Dr. Tony Fauci himself was forced to admit what had been known for nearly a year during a recent interview.

Speaking to MSNBC, Fauci suggested that some of the children currently being treated at medical facilities were hospitalized with COVID as opposed to “because of COVID.”

He added some children who are currently listed as being in the hospital with COVID may actually be receiving treatment for “a broken leg or appendicitis,” rather than for a severe reactions to the virus.

Yet with each injection, children are asked to take on a risk profile that is still not fully understood. Emerging data continues to point to the increased risks of myocarditis after COVID vaccination in younger populations.

A new study looked at 12 to 39 years old patients insured by Kaiser Permanente Northwest who received at least one dose of an mRNA vaccine (Pfizer-BioNTech or Moderna) between December 2020 and October 2021. The researchers concluded “The true incidence of myopericarditis is markedly higher than the incidence reported to US advisory committees.” How much higher? 1 in 2700 Boys 12-17 1 in 1860 for Men 18-24

Cardiologist Ramin Farzaneh-Far MD commented on Twitter stating:

While Vinay Prasad, MD MPH wrote:

The FDA also suffered recent two black eyes it hopes the public didn’t see. Presumably because of the agency’s rush to authorize boosters against a backdrop of missing data and uncertain safety outcomes, its two senior vaccine regulators stepped down in unison.

Marion Gruber, director of the FDA’s Office of Vaccines Research & Review, and deputy director Phil Krause will exit the agency in October and November, respectively.

At the time in late August 2021 Politico reported:

“…the agency is facing a potential mutiny among its staff and outside vaccine advisers, several of whom feel cut out of key decisions and who view the plan to offer boosters to all adults as premature and unnecessary.

The wrote further that “The tension within the administration plus open skepticism from outside experts has fueled finger-pointing and divisions among health agencies. Career scientists in particular have been confused and surprised by the process...

Jefferey Jaxen

Jefferey Jaxen is a health journalist and featured in his weekly segment, ’The Jaxen Report’, on The HighWire. As an investigative journalist, researcher, and compelling writer, Jefferey serves as Lead editor of The HighWire News and Opinion Team.

Other Headlines

Coronavirus

Senate hearing examines ‘available evidence’ on the origins of COVID-19

The Senate Homeland Security Governmental Affairs committee held a hearing and debate Tuesday morning regarding the origins of the COVID-19 pandemic. The hearing included two scientists who believe a zoonotic origin is the most likely explanation and two scientists who believe the virus was generated in a lab before leaking to the public. Gregory KoblentzContinue reading Senate hearing examines ‘available evidence’ on the origins of COVID-19

More news about Coronavirus

Health & Nutrition

USDA Claims Authority to Combat Bird Flu, Trains APHIS with FEMA Protocols

H5N1 fears are ramping up as the USDA seeks to give FEMA training to the Animal & Plant Health Inspection Service (APHIS). The notice appeared in the federal register and stated, “APHIS is assuming responsibility for providing certain Federal Emergency Management Agency (FEMA)-related training to APHIS employees. The training consists of courses such as IntroductionContinue reading USDA Claims Authority to Combat Bird Flu, Trains APHIS with FEMA Protocols

More news about Health & Nutrition

Vaccines

The CDC Recommends Everyone 6 Months and Older Gets a COVID-19 Vaccine This Fall

Despite low risk of severe COVID-19 infection for children and younger age groups, the CDC says children should get the vaccine. The CDC has released new guidance encouraging everyone over six months old to receive the latest COVID-19 and flu vaccines this fall to prepare for the winter season. This applies to everyone, whether orContinue reading The CDC Recommends Everyone 6 Months and Older Gets a COVID-19 Vaccine This Fall

More news about Vaccines

Science & Tech

USDA Reopens Comment Period for Deregulation of Gene-Edited Plants

The deregulation of gene-edited plants is on the USDA agenda, and the public comment period has been extended by 21 days. The comment page has yet to be posted on the Federal Register. CRISPR is a new technology that is being used in agriculture to modify plants. “New Gene Technologies” or NGTs are how big agricultural companies like Bayer areContinue reading USDA Reopens Comment Period for Deregulation of Gene-Edited Plants

More news about Science & Tech

Environment

Bayer Pushes for Liability Shield Against Glyphosate Lawsuits Amid Controversy and Lobbying Efforts

Bayer/Monsanto continues their push to create a liability shield against lawsuits for harm caused by Roundup and the primary chemical gglyphosate. The House Agriculture Committee approved language in the farm bill that would provide pesticide and herbicide manufacturers with complete immunity from charges. Bayer’s lobbying efforts at the state level failed in various states, includingContinue reading Bayer Pushes for Liability Shield Against Glyphosate Lawsuits Amid Controversy and Lobbying Efforts

More news about Environment

Policy

USDA Claims Authority to Combat Bird Flu, Trains APHIS with FEMA Protocols

H5N1 fears are ramping up as the USDA seeks to give FEMA training to the Animal & Plant Health Inspection Service (APHIS). The notice appeared in the federal register and stated, “APHIS is assuming responsibility for providing certain Federal Emergency Management Agency (FEMA)-related training to APHIS employees. The training consists of courses such as IntroductionContinue reading USDA Claims Authority to Combat Bird Flu, Trains APHIS with FEMA Protocols

More news about Policy